Nymox Pharmaceutical Corp
NYMX
NYMX was delisted on the 6th of July, 2023.
48 hedge funds and large institutions have $17.8M invested in Nymox Pharmaceutical Corp in 2018 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 14 increasing their positions, 11 reducing their positions, and 4 closing their positions.
175% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 4
27% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 11
25% more capital invested
Capital invested by funds: $14.3M → $17.8M (+$3.56M)
17% more funds holding
Funds holding: 41 → 48 (+7)
81% less call options, than puts
Call options by funds: $427K | Put options by funds: $2.21M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$257K |
| 2 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$213K |
| 3 |
BlackRock
New York
|
+$121K |
| 4 |
Brown Advisory
Baltimore,
Maryland
|
+$92.5K |
| 5 |
WCWM
Willow Creek Wealth Management
Sebastopol,
California
|
+$60.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCIM
TIAA CREF Investment Management
New York
|
-$255K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$235K |
| 3 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
-$191K |
| 4 |
TA
Teachers Advisors
New York
|
-$164K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$143K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Squarepoint
New York
| – | -$34K | -10,194 | Closed |
|
|
TRCT
52
Tower Research Capital (TRC)
New York
| – | -$6K | -1,851 | Closed |
|
NYMX Hedge Fund Activity: Q1 2018 in Review
48 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Nymox Pharmaceutical Corp (NYMX) for Q1 2018, worth a combined $17.8M — up 25% from $14.3M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new NYMX positions and 4 closed out — a net gain of 7 holders — while 14 added to existing stakes and 11 trimmed.
The largest buyer was State Street, adding an estimated $257K. The largest seller was TIAA CREF Investment Management, exiting entirely with an estimated $255K sold.
- 48 institutional investors held Nymox Pharmaceutical Corp (NYMX) as of Q1 2018, up from 41 in Q4 2017.
- Funds reported $17.8M of Nymox Pharmaceutical Corp stock for Q1 2018, up 25% quarter-over-quarter.
- 11 funds opened new Nymox Pharmaceutical Corp positions in Q1 2018 and 4 closed out, a net change of +7 holders.
- The largest Nymox Pharmaceutical Corp buyer in Q1 2018 was State Street, an estimated $257K added.
- The largest Nymox Pharmaceutical Corp seller in Q1 2018 was TIAA CREF Investment Management, an estimated $255K sold.
Based on aggregated 13F filings for Q1 2018.